about
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-medi...
Read More
2.46
-0.28
(-10.22%)
2.6M
XNAS Volume
XNAS 22 Oct, 2025 12:16 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Cabaletta Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..